IL1B and escherichia coli infection: Interestingly, when uroepithelial cells failed to release IL-1β in the presence of COX-2 inhibitor and even during E. coli infection, we observed increased expression of IL-1β in macrophages and NK cells which might be assumed to compensate the loss of effect in an in vivo model.